Skip to main content

Government News

pharma courses

  • Indian Pharmacopoeia to become digital

    At the pinnacle of the online era, the Indian Pharmacopoeia Commission (IPC) is set to digitize Indian Pharmacopoeia (IP) to increase its coverage.

    IPC has invited tender on Gem Portal (Government E Marketplace) from eligible and qualified IT firms related to online portal Development, application development, data digitalization or online content management etc for the project.

  • Mrs. Archna Mudgal has taken voluntary retirement from PCI

    Mrs. Archna Mudgal who was serving as registrar cum secretary has taken voluntary retirement from PCI, notified by Pharmacy council of India. And Mr Anil Mittal, Deputy Secretary has taken charge as Registrar-cum-Secretary.

    A notification published on Pharmacy Council of India (PCI) portal said, "Due to Voluntary Retirement taken by Smt. Archna Mudgal, Registrar-cum-Secretary, PCI, Shri Anil Mittal, Deputy Secretary will hold the charge of Registrar-cum-Secretary."

  • India is among the top five countries for production of medical devices, Dr Jitendra Singh

    Union Minister for Science and Technology Dr Jitendra Singh today said, India is among the top five countries in the world manufacturing life-saving high risk medical devices but the cost of our devices is about one-third of those manufactured by the other four countries.

  • HC directed the government to re examine samples of J&J baby powder

    On Monday, the Mumbai High Court directed the Maharashtra government to re-examine samples of Johnson & Johnson baby powder produced in government or government approved labs.

    The division bench of Justices SV Gangapurwala and SG Dige asked additional government pleader Milind More to submit names of labs on November 16.

  • Odisha Pharmacy Council dissolved due to financial irregularities

    The state government has dissolved Odisha Pharmacy Council (OPC) and all the present council members have been debarred from attending any meetings of the council over alleged financial irregularities and improper management.

    The decision to dissolve OPC was taken based on the recommendations submitted by the enquiry committee headed by the Director of Medical Education and Training (DMET), Government of Odisha. The Committee also recommended a fresh election.

  • Study unveils protein synthesis in red blood cells

    The process by which the mRNA codes for a particular protein is known as translation. It is the final step in which an mRNA carrying information from DNA synthesises proteins. It is a necessary process performed by almost all living cells, leaving erythrocytes (Reb Blood Cells or RBCs), which are believed to be the only exception. A research team led by Sandeep M Eswarappa, Associate Professor, Department of Biochemistry, Indian Institute of Science, Bengaluru, has identified that mature human RBCs can also make their proteins.

  • Indian Pharmacopoeia Commission clarifies on three new chapters

    Indian Pharmacopoeia Commission clarifies on three new general chapters introduced in Indian Pharmacopoeia 2022 which are on Uniformity of Dosage Units, Elemental Impurities and Nitrosamine Impurities.

    Indian Pharmacopoeia Commission (IPC) has published the Indian Pharmacopoeia (IP) 2022 and Hon ble Union Health Minister released the 9th edition of IP 2022 in July, 2022 in Vigyan Bhawan. New Delhi.

  • PCI mandates to implement PPR 2015

    The Pharmacy Council of India (PCI) has directed all the State and Union Territory (UT) governments and State Pharmacy Council to immediately implement the Pharmacy Practice Regulations (PPR), 2015. In January 2015, PCI had already notified about the implementation of the PPR,2015.

  • Government strengthening Genome Sequencing of new variant

    Union Minister of Health and Family Welfare, Dr Mansukh Mandaviya today chaired a meeting with public health experts and officials to review the COVID19 pandemic situation in the country, status of vaccination drive and the Global scenario of new variants of Covid-19.Dr. V K Paul, Member (Health) NITI Aayog was also present during the meeting.

  • Indian Immunologicals to invest Rs 700 Crores to set up animal vaccine plant

    Indian Immunologicals Limited (IIL) announced that the company will invest about Rs 700 Crores to set up a new animal vaccine manufacturing facility in Genome Valley, Hyderabad.

    The IIL, a subsidiary of the National Dairy Development Board (NDDB), is already one of the world’s largest FMD vaccine manufacturers. It is also the leading vaccine supplier to the Government of India’s National Animal Disease Control Programme (NADCP).

Subscribe to Government News